This report aims to provide a comprehensive study of the global market for Pet OTC Medication. Report Highlights:

(1) Global Pet OTC Medication market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Pet OTC Medication market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Pet OTC Medication market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Pet OTC Medication segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Pet OTC Medication segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Pet OTC Medication, capacity, production and trends.

(7) Pet OTC Medication industry supply chain, upstream, midstream and downstream analysis.

According to latest study, the global market for Pet OTC Medication should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Pet OTC Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Pet OTC Medication market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Tablets segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Pet Specialty Stores has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Pet OTC Medication include Bayer AG, Boehringer Ingelheim International GmbH, Covetrus, Dechra Pharmaceuticals, Elanco Animal Health, Heska, IDEXX Laboratories, Kyoritsu Seiyaku and Merck & Co., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Tablets

Capsules

Sprays

Market segment by application, can be divided into

Pet Specialty Stores

Veterinary Clinics

Others

Market segment by players, this report covers

Bayer AG

Boehringer Ingelheim International GmbH

Covetrus

Dechra Pharmaceuticals

Elanco Animal Health

Heska

IDEXX Laboratories

Kyoritsu Seiyaku

Merck & Co.

Phibro Animal Health

Sequent Scientific

Vetoquinol SA

Virbac SA

Zoetis

1 Market Overview

1.1 Pet OTC Medication Definition

1.2 Global Pet OTC Medication Market Size and Forecast

1.2.1 By Revenue, Global Pet OTC Medication Market Size, 2018-2029

1.2.2 By Sales Volume, Global Pet OTC Medication Market Size, 2018-2029

1.2.3 Global Pet OTC Medication Price Trend, 2018-2029

1.3 China Pet OTC Medication Market Size and Forecast

1.3.1 By Revenue, China Pet OTC Medication Market Size, 2018-2029

1.3.2 By Sales Volume, China Pet OTC Medication Market Size, 2018-2029

1.3.3 China Pet OTC Medication Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Pet OTC Medication Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Pet OTC Medication Share in Global Market, 2018-2029

1.4.3 Pet OTC Medication Market Size: China VS Global, 2018-2029

1.5 Pet OTC Medication Market Dynamics

1.5.1 Pet OTC Medication Market Drivers

1.5.2 Pet OTC Medication Market Restraints

1.5.3 Pet OTC Medication Industry Trends

1.5.4 Pet OTC Medication Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Pet OTC Medication Revenue by Company, 2018-2023

2.2 Global Pet OTC Medication Sales Volume by Company, 2018-2023

2.3 Global Pet OTC Medication Price by Company, 2018-2023

2.4 Global Pet OTC Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Pet OTC Medication Concentration Ratio

2.6 Global Pet OTC Medication Mergers & Acquisitions, Expansion Plans

2.7 Global Pet OTC Medication Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Pet OTC Medication Revenue by Company, 2018-2023

3.2 China Pet OTC Medication Sales Volume by Company, 2018-2023

3.3 China Pet OTC Medication Pet OTC Medication Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Pet OTC Medication Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Pet OTC Medication Domestic VS Export

3.6 China Market, Pet OTC Medication Import & Export

3.6.1 China Market, Pet OTC Medication Import & Export, 2018-2029

3.6.2 China Pet OTC Medication Import & Export Trends

3.6.3 Main Sources of China Pet OTC Medication Import

3.6.4 Export Destination of China Pet OTC Medication

4 Pet OTC Medication Production by Region

4.1 Global Pet OTC Medication Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Pet OTC Medication Manufacturers

4.3 Global Major Manufacturers, Pet OTC Medication Capacity Expansion and Future Plans

4.4 Global Pet OTC Medication Capacity by Region

4.5 Global Pet OTC Medication Production by Region

4.5.1 Global Pet OTC Medication Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Pet OTC Medication Production by Region, 2018-2023

4.5.3 Global Pet OTC Medication Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Pet OTC Medication Industry Chain

5.2 Pet OTC Medication Upstream Analysis

5.2.1 Pet OTC Medication Core Raw Materials

5.2.2 Main Manufacturers of Pet OTC Medication Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Pet OTC Medication Production Mode

5.6 Pet OTC Medication Procurement Model

5.7 Pet OTC Medication Industry Sales Model and Sales Channels

5.7.1 Pet OTC Medication Sales Model

5.7.2 Pet OTC Medication Typical Distributors

6 Sights by Type

6.1 Pet OTC Medication Classification

6.1.1 Tablets

6.1.2 Capsules

6.1.3 Sprays

6.2 By Type, Global Pet OTC Medication Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Pet OTC Medication Revenue, 2018-2029

6.4 By Type, Global Pet OTC Medication Sales Volume, 2018-2029

6.5 By Type, Global Pet OTC Medication Price, 2018-2029

7 Sights by Application

7.1 Pet OTC Medication Segment by Application

7.1.1 Pet Specialty Stores

7.1.2 Veterinary Clinics

7.1.3 Others

7.2 By Application, Global Pet OTC Medication Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Pet OTC Medication Revenue, 2018-2029

7.4 By Application, Global Pet OTC Medication Sales Volume, 2018-2029

7.5 By Application, Global Pet OTC Medication Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Pet OTC Medication Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Pet OTC Medication Revenue, 2018-2029

8.3 By Region, Global Pet OTC Medication Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Pet OTC Medication Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Pet OTC Medication Market Size Market Share

8.5 Europe

8.5.1 Europe Pet OTC Medication Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Pet OTC Medication Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Pet OTC Medication Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Pet OTC Medication Market Size Market Share

8.7 South America

8.7.1 South America Pet OTC Medication Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Pet OTC Medication Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Pet OTC Medication Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Pet OTC Medication Revenue, 2018-2029

9.3 By Country, Global Pet OTC Medication Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Pet OTC Medication Market Size, 2018-2029

9.4.2 By Company, U.S. Pet OTC Medication Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Pet OTC Medication Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Pet OTC Medication Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Pet OTC Medication Market Size, 2018-2029

9.5.2 By Company, Europe Pet OTC Medication Sales Volume Market Share, 2022

9.5.3 By Type, Europe Pet OTC Medication Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Pet OTC Medication Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Pet OTC Medication Market Size, 2018-2029

9.6.2 By Company, China Pet OTC Medication Sales Volume Market Share, 2022

9.6.3 By Type, China Pet OTC Medication Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Pet OTC Medication Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Pet OTC Medication Market Size, 2018-2029

9.7.2 By Company, Japan Pet OTC Medication Sales Volume Market Share, 2022

9.7.3 By Type, Japan Pet OTC Medication Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Pet OTC Medication Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Pet OTC Medication Market Size, 2018-2029

9.8.2 By Company, South Korea Pet OTC Medication Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Pet OTC Medication Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Pet OTC Medication Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Pet OTC Medication Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Pet OTC Medication Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Pet OTC Medication Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Pet OTC Medication Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Pet OTC Medication Market Size, 2018-2029

9.10.2 By Company, India Pet OTC Medication Sales Volume Market Share, 2022

9.10.3 By Type, India Pet OTC Medication Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Pet OTC Medication Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Pet OTC Medication Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Pet OTC Medication Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Pet OTC Medication Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Pet OTC Medication Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Bayer AG

10.1.1 Bayer AG Company Information, Head Office, Market Area and Industry Position

10.1.2 Bayer AG Pet OTC Medication Models, Specifications and Application

10.1.3 Bayer AG Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Bayer AG Company Profile and Main Business

10.1.5 Bayer AG Recent Developments

10.2 Boehringer Ingelheim International GmbH

10.2.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position

10.2.2 Boehringer Ingelheim International GmbH Pet OTC Medication Models, Specifications and Application

10.2.3 Boehringer Ingelheim International GmbH Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Boehringer Ingelheim International GmbH Company Profile and Main Business

10.2.5 Boehringer Ingelheim International GmbH Recent Developments

10.3 Covetrus

10.3.1 Covetrus Company Information, Head Office, Market Area and Industry Position

10.3.2 Covetrus Pet OTC Medication Models, Specifications and Application

10.3.3 Covetrus Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Covetrus Company Profile and Main Business

10.3.5 Covetrus Recent Developments

10.4 Dechra Pharmaceuticals

10.4.1 Dechra Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.4.2 Dechra Pharmaceuticals Pet OTC Medication Models, Specifications and Application

10.4.3 Dechra Pharmaceuticals Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Dechra Pharmaceuticals Company Profile and Main Business

10.4.5 Dechra Pharmaceuticals Recent Developments

10.5 Elanco Animal Health

10.5.1 Elanco Animal Health Company Information, Head Office, Market Area and Industry Position

10.5.2 Elanco Animal Health Pet OTC Medication Models, Specifications and Application

10.5.3 Elanco Animal Health Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Elanco Animal Health Company Profile and Main Business

10.5.5 Elanco Animal Health Recent Developments

10.6 Heska

10.6.1 Heska Company Information, Head Office, Market Area and Industry Position

10.6.2 Heska Pet OTC Medication Models, Specifications and Application

10.6.3 Heska Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Heska Company Profile and Main Business

10.6.5 Heska Recent Developments

10.7 IDEXX Laboratories

10.7.1 IDEXX Laboratories Company Information, Head Office, Market Area and Industry Position

10.7.2 IDEXX Laboratories Pet OTC Medication Models, Specifications and Application

10.7.3 IDEXX Laboratories Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 IDEXX Laboratories Company Profile and Main Business

10.7.5 IDEXX Laboratories Recent Developments

10.8 Kyoritsu Seiyaku

10.8.1 Kyoritsu Seiyaku Company Information, Head Office, Market Area and Industry Position

10.8.2 Kyoritsu Seiyaku Pet OTC Medication Models, Specifications and Application

10.8.3 Kyoritsu Seiyaku Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Kyoritsu Seiyaku Company Profile and Main Business

10.8.5 Kyoritsu Seiyaku Recent Developments

10.9 Merck & Co.

10.9.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position

10.9.2 Merck & Co. Pet OTC Medication Models, Specifications and Application

10.9.3 Merck & Co. Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Merck & Co. Company Profile and Main Business

10.9.5 Merck & Co. Recent Developments

10.10 Phibro Animal Health

10.10.1 Phibro Animal Health Company Information, Head Office, Market Area and Industry Position

10.10.2 Phibro Animal Health Pet OTC Medication Models, Specifications and Application

10.10.3 Phibro Animal Health Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Phibro Animal Health Company Profile and Main Business

10.10.5 Phibro Animal Health Recent Developments

10.11 Sequent Scientific

10.11.1 Sequent Scientific Company Information, Head Office, Market Area and Industry Position

10.11.2 Sequent Scientific Pet OTC Medication Models, Specifications and Application

10.11.3 Sequent Scientific Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Sequent Scientific Company Profile and Main Business

10.11.5 Sequent Scientific Recent Developments

10.12 Vetoquinol SA

10.12.1 Vetoquinol SA Company Information, Head Office, Market Area and Industry Position

10.12.2 Vetoquinol SA Pet OTC Medication Models, Specifications and Application

10.12.3 Vetoquinol SA Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Vetoquinol SA Company Profile and Main Business

10.12.5 Vetoquinol SA Recent Developments

10.13 Virbac SA

10.13.1 Virbac SA Company Information, Head Office, Market Area and Industry Position

10.13.2 Virbac SA Pet OTC Medication Models, Specifications and Application

10.13.3 Virbac SA Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Virbac SA Company Profile and Main Business

10.13.5 Virbac SA Recent Developments

10.14 Zoetis

10.14.1 Zoetis Company Information, Head Office, Market Area and Industry Position

10.14.2 Zoetis Pet OTC Medication Models, Specifications and Application

10.14.3 Zoetis Pet OTC Medication Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Zoetis Company Profile and Main Business

10.14.5 Zoetis Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Pet OTC Medication Market Size & CAGR: China VS Global, 2018-2029, US$ Million_x000D_

Table 2. Pet OTC Medication Market Restraints_x000D_

Table 3. Pet OTC Medication Market Trends_x000D_

Table 4. Pet OTC Medication Industry Policy_x000D_

Table 5. Global Pet OTC Medication Revenue by Company, 2018-2023, US$ million_x000D_

Table 6. Global Pet OTC Medication Revenue Market Share by Company, 2018-2023_x000D_

Table 7. Global Pet OTC Medication Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 8. Global Pet OTC Medication Sales Volume Market Share by Company, 2018-2023_x000D_

Table 9. Global Pet OTC Medication Price by Company, 2018-2023, (US$/Unit)_x000D_

Table 10. Global Pet OTC Medication Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_

Table 11. Global Pet OTC Medication Mergers & Acquisitions, Expansion Plans_x000D_

Table 12. Global Pet OTC Medication Manufacturers Product Type_x000D_

Table 13. China Pet OTC Medication Revenue by Company, 2018-2023, US$ million_x000D_

Table 14. China Pet OTC Medication Revenue Market Share by Company, 2018-2023_x000D_

Table 15. China Pet OTC Medication Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 16. China Pet OTC Medication Sales Volume Market Share by Company, 2018-2023_x000D_

Table 17. China Market, Pet OTC Medication Production, Sales, Import and Export, 2018-2029, (K Units)_x000D_

Table 18. China Pet OTC Medication Import & Export Trends_x000D_

Table 19. Main Sources of China Pet OTC Medication Import_x000D_

Table 20. Export Destination of China Pet OTC Medication_x000D_

Table 21. Global Headquarters and Manufacturing Base of Pet OTC Medication Manufacturers_x000D_

Table 22. Global Major Manufacturers, Pet OTC Medication Capacity Expansion and Future Plans_x000D_

Table 23. Global Pet OTC Medication Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)_x000D_

Table 24. Global Pet OTC Medication Production by Region, 2018-2023, (K Units)_x000D_

Table 25. Global Pet OTC Medication Production Forecast by Region, 2023-2029, (K Units)_x000D_

Table 26. Global Key Players of Pet OTC Medication Upstream (Raw Materials)_x000D_

Table 27. Global Pet OTC Medication Typical Customers_x000D_

Table 28. Pet OTC Medication Typical Distributors_x000D_

Table 29. By Type, Global Pet OTC Medication Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 30. By Application, Global Pet OTC Medication Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 31. By Region, Global Pet OTC Medication Market Size, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 32. By Region, Global Pet OTC Medication Revenue, 2018-2029, US$ Million_x000D_

Table 33. By Region, Global Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Table 34. By Country, Global Pet OTC Medication Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million_x000D_

Table 35. By Country, Global Pet OTC Medication Revenue, 2018-2029, US$ Million_x000D_

Table 36. By Country, Global Pet OTC Medication Revenue Market Share, 2018-2029_x000D_

Table 37. By Country, Global Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Table 38. By Country, Global Pet OTC Medication Sales Volume Market Share, 2018-2029_x000D_

Table 39. Bayer AG Company Information, Head Office, Market Area and Industry Position_x000D_

Table 40. Bayer AG Pet OTC Medication Models, Specifications and Application_x000D_

Table 41. Bayer AG Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 42. Bayer AG Company Profile and Main Business_x000D_

Table 43. Bayer AG Recent Developments_x000D_

Table 44. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position_x000D_

Table 45. Boehringer Ingelheim International GmbH Pet OTC Medication Models, Specifications and Application_x000D_

Table 46. Boehringer Ingelheim International GmbH Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 47. Boehringer Ingelheim International GmbH Company Profile and Main Business_x000D_

Table 48. Boehringer Ingelheim International GmbH Recent Developments_x000D_

Table 49. Covetrus Company Information, Head Office, Market Area and Industry Position_x000D_

Table 50. Covetrus Pet OTC Medication Models, Specifications and Application_x000D_

Table 51. Covetrus Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 52. Covetrus Company Profile and Main Business_x000D_

Table 53. Covetrus Recent Developments_x000D_

Table 54. Dechra Pharmaceuticals Company Information, Head Office, Market Area and Industry Position_x000D_

Table 55. Dechra Pharmaceuticals Pet OTC Medication Models, Specifications and Application_x000D_

Table 56. Dechra Pharmaceuticals Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 57. Dechra Pharmaceuticals Company Profile and Main Business_x000D_

Table 58. Dechra Pharmaceuticals Recent Developments_x000D_

Table 59. Elanco Animal Health Company Information, Head Office, Market Area and Industry Position_x000D_

Table 60. Elanco Animal Health Pet OTC Medication Models, Specifications and Application_x000D_

Table 61. Elanco Animal Health Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 62. Elanco Animal Health Company Profile and Main Business_x000D_

Table 63. Elanco Animal Health Recent Developments_x000D_

Table 64. Heska Company Information, Head Office, Market Area and Industry Position_x000D_

Table 65. Heska Pet OTC Medication Models, Specifications and Application_x000D_

Table 66. Heska Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 67. Heska Company Profile and Main Business_x000D_

Table 68. Heska Recent Developments_x000D_

Table 69. IDEXX Laboratories Company Information, Head Office, Market Area and Industry Position_x000D_

Table 70. IDEXX Laboratories Pet OTC Medication Models, Specifications and Application_x000D_

Table 71. IDEXX Laboratories Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 72. IDEXX Laboratories Company Profile and Main Business_x000D_

Table 73. IDEXX Laboratories Recent Developments_x000D_

Table 74. Kyoritsu Seiyaku Company Information, Head Office, Market Area and Industry Position_x000D_

Table 75. Kyoritsu Seiyaku Pet OTC Medication Models, Specifications and Application_x000D_

Table 76. Kyoritsu Seiyaku Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 77. Kyoritsu Seiyaku Company Profile and Main Business_x000D_

Table 78. Kyoritsu Seiyaku Recent Developments_x000D_

Table 79. Merck & Co. Company Information, Head Office, Market Area and Industry Position_x000D_

Table 80. Merck & Co. Pet OTC Medication Models, Specifications and Application_x000D_

Table 81. Merck & Co. Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 82. Merck & Co. Company Profile and Main Business_x000D_

Table 83. Merck & Co. Recent Developments_x000D_

Table 84. Phibro Animal Health Company Information, Head Office, Market Area and Industry Position_x000D_

Table 85. Phibro Animal Health Pet OTC Medication Models, Specifications and Application_x000D_

Table 86. Phibro Animal Health Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 87. Phibro Animal Health Company Profile and Main Business_x000D_

Table 88. Phibro Animal Health Recent Developments_x000D_

Table 89. Sequent Scientific Company Information, Head Office, Market Area and Industry Position_x000D_

Table 90. Sequent Scientific Pet OTC Medication Models, Specifications and Application_x000D_

Table 91. Sequent Scientific Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 92. Sequent Scientific Company Profile and Main Business_x000D_

Table 93. Sequent Scientific Recent Developments_x000D_

Table 94. Vetoquinol SA Company Information, Head Office, Market Area and Industry Position_x000D_

Table 95. Vetoquinol SA Pet OTC Medication Models, Specifications and Application_x000D_

Table 96. Vetoquinol SA Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 97. Vetoquinol SA Company Profile and Main Business_x000D_

Table 98. Vetoquinol SA Recent Developments_x000D_

Table 99. Virbac SA Company Information, Head Office, Market Area and Industry Position_x000D_

Table 100. Virbac SA Pet OTC Medication Models, Specifications and Application_x000D_

Table 101. Virbac SA Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 102. Virbac SA Company Profile and Main Business_x000D_

Table 103. Virbac SA Recent Developments_x000D_

Table 104. Zoetis Company Information, Head Office, Market Area and Industry Position_x000D_

Table 105. Zoetis Pet OTC Medication Models, Specifications and Application_x000D_

Table 106. Zoetis Pet OTC Medication Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 107. Zoetis Company Profile and Main Business_x000D_

Table 108. Zoetis Recent Developments_x000D_

List of Figure_x000D_

Figure 1. Pet OTC Medication Picture_x000D_

Figure 2. By Revenue, Global Pet OTC Medication Market Size and Forecast, 2018-2029, US$ Million_x000D_

Figure 3. By Sales Volume, Global Pet OTC Medication Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 4. Global Pet OTC Medication Price Trend, 2018-2029, (US$/Unit)_x000D_

Figure 5. By Revenue, China Pet OTC Medication Market Size and Forecast, 2018-2029, US$ million_x000D_

Figure 6. By Sales Volume, China Pet OTC Medication Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 7. China Pet OTC Medication Price Trend, 2018-2029 (US$/Unit)_x000D_

Figure 8. By Revenue, China Pet OTC Medication Share of Global Market, 2018-2029_x000D_

Figure 9. By Sales Volume, China Pet OTC Medication Share of Global Market, 2018-2029_x000D_

Figure 10. Global Pet OTC Medication Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 11. Global Pet OTC Medication Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022_x000D_

Figure 12. China Pet OTC Medication Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 13. China Pet OTC Medication Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 14. China Pet OTC Medication Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023_x000D_

Figure 15. Chinese Local Players, Proportion of Pet OTC Medication Domestic VS Export, 2022_x000D_

Figure 16. Global Pet OTC Medication Capacity, Production and Capacity Utilization, 2018-2029_x000D_

Figure 17. Global Pet OTC Medication Capacity Market Share by Region, 2022 VS 2029_x000D_

Figure 18. Global Pet OTC Medication Production Market Share & Forecast by Region, 2018-2029_x000D_

Figure 19. Pet OTC Medication Industry Chain_x000D_

Figure 20. Pet OTC Medication Procurement Model_x000D_

Figure 21. Pet OTC Medication Sales Model_x000D_

Figure 22. Pet OTC Medication Sales Channels, Direct Sales and Distribution_x000D_

Figure 23. Tablets_x000D_

Figure 24. Capsules_x000D_

Figure 25. Sprays_x000D_

Figure 26. By Type, Global Pet OTC Medication Revenue, 2018-2029, US$ Million_x000D_

Figure 27. By Type, Global Pet OTC Medication Revenue Market Share, 2018-2029_x000D_

Figure 28. By Type, Global Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 29. By Type, Global Pet OTC Medication Sales Volume Market Share, 2018-2029_x000D_

Figure 30. By Type, Global Pet OTC Medication Price, 2018-2029, (US$/Unit)_x000D_

Figure 31. Pet Specialty Stores_x000D_

Figure 32. Veterinary Clinics_x000D_

Figure 33. Others_x000D_

Figure 34. By Application, Global Pet OTC Medication Revenue, 2018-2029, US$ Million_x000D_

Figure 35. By Application, Global Pet OTC Medication Revenue Market Share, 2018-2029_x000D_

Figure 36. By Application, Global Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 37. By Application, Global Pet OTC Medication Sales Volume Market Share, 2018-2029_x000D_

Figure 38. By Application, Global Pet OTC Medication Price, 2018-2029, (US$/Unit)_x000D_

Figure 39. By Region, Global Pet OTC Medication Revenue Market Share, 2018-2029_x000D_

Figure 40. By Region, Global Pet OTC Medication Sales Volume Market Share, 2018-2029_x000D_

Figure 41. North America Pet OTC Medication Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 42. By Country, North America Pet OTC Medication Revenue Market Share, 2022_x000D_

Figure 43. Europe Pet OTC Medication Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 44. By Country, Europe Pet OTC Medication Revenue Market Share, 2022_x000D_

Figure 45. Asia Pacific Pet OTC Medication Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 46. By Country/Region, Asia Pacific Pet OTC Medication Revenue Market Share, 2022_x000D_

Figure 47. South America Pet OTC Medication Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 48. By Country, South America Pet OTC Medication Revenue Market Share, 2022_x000D_

Figure 49. Middle East & Africa Pet OTC Medication Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 50. U.S. Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 51. By Company, U.S. Pet OTC Medication Market Share, 2022_x000D_

Figure 52. By Type, U.S. Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 53. By Application, U.S. Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 54. Europe Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 55. By Company, Europe Pet OTC Medication Market Share, 2022_x000D_

Figure 56. By Type, Europe Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 57. By Application, Europe Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 58. China Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 59. By Company, China Pet OTC Medication Market Share, 2022_x000D_

Figure 60. By Type, China Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 61. By Application, China Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 62. Japan Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 63. By Company, Japan Pet OTC Medication Market Share, 2022_x000D_

Figure 64. By Type, Japan Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 65. By Application, Japan Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 66. South Korea Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 67. By Company, South Korea Pet OTC Medication Market Share, 2022_x000D_

Figure 68. By Type, South Korea Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 69. By Application, South Korea Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 70. Southeast Asia Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 71. By Company, Southeast Asia Pet OTC Medication Market Share, 2022_x000D_

Figure 72. By Type, Southeast Asia Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 73. By Application, Southeast Asia Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 74. India Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 75. By Company, India Pet OTC Medication Market Share, 2022_x000D_

Figure 76. By Type, India Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 77. By Application, India Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 78. Middle East & Asia Pet OTC Medication Sales Volume, 2018-2029, (K Units)_x000D_

Figure 79. By Company, Middle East & Asia Pet OTC Medication Market Share, 2022_x000D_

Figure 80. By Type, Middle East & Asia Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 81. By Application, Middle East & Asia Pet OTC Medication Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 82. Research Methodology_x000D_

Figure 83. Breakdown of Primary Interviews_x000D_

Figure 84. Bottom-up Approaches_x000D_

Figure 85. Top-down Approaches_x000D_

_x000D_

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)